Patient Activity and Survival Following Implantable Cardioverter-Defibrillator Implantation: The ALTITUDE Activity Study

被引:50
|
作者
Kramer, Daniel B. [1 ,2 ,3 ]
Mitchell, Susan L. [1 ,2 ,3 ]
Monteiro, Joao [4 ]
Jones, Paul W. [5 ]
Normand, Sharon-Lise [2 ,6 ]
Hayes, David L. [7 ]
Reynolds, Matthew R. [8 ,9 ]
机构
[1] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA
[2] Harvard Univ, Sch Med, Boston, MA USA
[3] Hebrew SeniorLife Inst Aging Res, Boston, MA USA
[4] North Amer Sci Associates Inc, Minneapolis, MN USA
[5] Boston Sci, St Paul, MN USA
[6] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA
[7] Mayo Clin, Rochester, MN USA
[8] Lahey Clin Fdn, Burlington, MA USA
[9] Harvard Clin Res Inst, Boston, MA USA
来源
JOURNAL OF THE AMERICAN HEART ASSOCIATION | 2015年 / 4卷 / 05期
关键词
death; implantable cardioverter-defibrillators; sudden; CARDIAC RESYNCHRONIZATION THERAPY; HEART-FAILURE; PHYSICAL-ACTIVITY; SHOCK THERAPY; MORTALITY; RISK; REPLACEMENT; DEVICES; VALIDATION; RECIPIENTS;
D O I
10.1161/JAHA.115.001775
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background-Physical activity data are collected automatically by implantable cardioverter-defibrillators (ICDs). Though these data potentially provide a quantifiable and easily accessible measure of functional status, its relationship with survival has not been well studied. Methods and Results-Patients enrolled in the Boston Scientific LATITUDE remote monitoring system from 2008 to 2012 with ICDs were eligible. Remote monitoring data were used to calculate mean daily activity at baseline (30 to 60 days after implantation), and longitudinally. Cox regression was used to examine the association between survival and increments of 30 minutes/day in both (1) mean baseline activity and (2) time-varying activity, with both adjusted for demographic and device characteristics. A total of 98 437 patients were followed for a median of 2.2 years (mean age of 67.7 +/- 13.1 years; 71.7% male). Mean baseline daily activity was 107.5 +/- 66.2 minutes/day. The proportion of patients surviving after 4 years was significantly higher among those in the most versus least active quintile of mean baseline activity (90.5% vs. 50.0%; log-rank P value, <0.001). Lower mean baseline activity (i.e., incremental difference of 30-minutes/day) was independently associated with a higher risk of death (adjusted hazard ratio [AHR], 1.44; 95% confidence interval [CI], 1.427 to 1.462). Time-varying activity was similarly associated with a higher risk of death (AHR, 1.48; 95% CI, 1.451 to 1.508), indicating that a patient having 30 minutes per day less activity in a given month has a 48% increased hazard for death when compared to a similar patient in the same month. Conclusions-Patient activity measured by ICDs strongly correlates with survival following ICD implantation.
引用
收藏
页数:7
相关论文
共 50 条
  • [41] Long-Term Benefit of Primary Prevention With an Implantable Cardioverter-Defibrillator An Extended 8-Year Follow-Up Study of the Multicenter Automatic Defibrillator Implantation Trial II
    Goldenberg, Ilan
    Gillespie, John
    Moss, Arthur J.
    Hall, W. Jackson
    Klein, Helmut
    McNitt, Scott
    Brown, Mary W.
    Cygankiewicz, Iwona
    Zareba, Wojciech
    CIRCULATION, 2010, 122 (13) : 1265 - 1271
  • [42] Development of an Entirely Subcutaneous Implantable Cardioverter-Defibrillator
    Lupo, Pier Paolo
    Pelissero, Gabriele
    Ali, Hussam
    Sanghera, Rick
    Cappato, Riccardo
    PROGRESS IN CARDIOVASCULAR DISEASES, 2012, 54 (06) : 493 - 497
  • [43] Understanding Implantable Cardioverter-Defibrillator Shocks and Mortality
    Williams, Eric S.
    Poole, Jeanne E.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2013, 62 (18) : 1680 - 1682
  • [44] Dutch outcome in implantable cardioverter-defibrillator therapy (DO-IT): registry design and baseline characteristics of a prospective observational cohort study to predict appropriate indication for implantable cardioverter-defibrillator
    van Barreveld, M.
    Dijkgraaf, M. G. W.
    Hulleman, M.
    Boersma, L. V. A.
    Delnoy, P. P. H. M.
    Meine, M.
    Tuinenburg, A. E.
    Theuns, D. A. M. J.
    van der Voort, P. H.
    Kimman, G. P.
    Buskens, E.
    Tijssen, J. P. G.
    Bruinsma, N.
    Verstraelen, T. E.
    Zwinderman, A. H.
    van Dessel, P. H. F. M.
    Wilde, A. A. M.
    NETHERLANDS HEART JOURNAL, 2017, 25 (10) : 574 - 580
  • [45] Dutch outcome in implantable cardioverter-defibrillator therapy (DO-IT): registry design and baseline characteristics of a prospective observational cohort study to predict appropriate indication for implantable cardioverter-defibrillator
    M. van Barreveld
    M. G. W. Dijkgraaf
    M. Hulleman
    L. V. A. Boersma
    P. P. H. M. Delnoy
    M. Meine
    A. E. Tuinenburg
    D. A. M. J. Theuns
    P. H. van der Voort
    G. P. Kimman
    E. Buskens
    J. P. G. Tijssen
    N. Bruinsma
    T. E. Verstraelen
    A. H. Zwinderman
    P. H. F. M. van Dessel
    A. A. M. Wilde
    Netherlands Heart Journal, 2017, 25 : 574 - 580
  • [46] Mortality risk following replacement implantable cardioverter-defibrillator implantation at end of battery life: Results from the NCDR®
    Kramer, Daniel B.
    Kennedy, Kevin F.
    Spertus, John A.
    Normand, Sharon-Lise
    Noseworthy, Peter A.
    Buxton, Alfred E.
    Josephson, Mark E.
    Zimetbaum, Peter J.
    Mitchell, Susan L.
    Reynolds, Matthew R.
    HEART RHYTHM, 2014, 11 (02) : 216 - 221
  • [47] Effect of malnutrition on outcomes of patients hospitalized for implantable cardioverter-defibrillator implantation
    Asemota, Iriagbonse Rotimi
    Shaka, Hafeez
    Akuna, Emmanuel
    Edigin, Ehizogie
    Adeoti, Oluwatomi
    HEART RHYTHM, 2022, 19 (05) : 858 - 859
  • [48] Implantable cardioverter-defibrillator therapy in the elderly: The continuing quest for data
    Barsheshet, Alon
    Huang, David T.
    CARDIOLOGY JOURNAL, 2011, 18 (05) : 473 - 475
  • [49] Subcutaneous Implantable Cardioverter-Defibrillator Technology
    Gupta, Anurag
    Al-Ahmad, Amin
    Wang, Paul J.
    HEART FAILURE CLINICS, 2011, 7 (02) : 287 - +
  • [50] Implantable cardioverter-defibrillator prescription in the elderly
    Epstein, Andrew E.
    Kay, G. Neal
    Plumb, Vance J.
    McElderry, H. Thomas
    Doppalapudi, Harish
    Yamada, Takumi
    Shafiroff, Jeff
    Syed, Zaffer A.
    Shkurovich, Sergio
    HEART RHYTHM, 2009, 6 (08) : 1136 - 1143